This is an auto-generated stub page built from atlas entry frontmatter. A richer
hand-crafted page is planned. See the
atlas source
for the full entry including detailed body sections.
il-36
IL-36
IL-36 cytokines (IL-36α/β/γ, chr2q12) signal via IL-36R/IL-1RAcP → NF-κB; IL-36Ra antagonist limits signaling. IL36RN loss-of-function drives generalized pustular psoriasis (GPP); spesolimab (anti-IL-36R; FDA 2022) targets GPP. Amplifies IL-17/IL-23 axis in skin and entheses.
Entry Metadata
| Field | Value |
|---|---|
| ID | il-36 |
| Name | IL-36 |
| Status | draft |
| Last reviewed | 2026-06-07 |
| Atlas | 01-human |
| Scale | 03-molecular |
Cross-Atlas Connections
Sources
- Marrakchi S, Guigue P, Renshaw BR, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011;365(7):620-628. · PubMed 21848462
- Bachelez H, Choon SE, Marrakchi S, et al. Spesolimab for generalized pustular psoriasis. N Engl J Med. 2021;385(26):2431-2440. · PubMed 34941024
- Gresnigt MS, van de Veerdonk FL. Biology of IL-36 cytokines and their role in disease. Semin Immunol. 2013;25(6):458-465. · PubMed 24289416
- Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376(10):957-970. · PubMed 28273019